229 related articles for article (PubMed ID: 22608344)
21. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
22. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
23. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
Escobar C; Barrios V; Jimenez D
Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
[TBL] [Abstract][Full Text] [Related]
24. Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
Alvarez Bravo G; Orts Castro E; Carvalho Monteiro G; López Zuazo I
J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):e192-e193. PubMed ID: 28663010
[TBL] [Abstract][Full Text] [Related]
25. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
Bissig D; Manjunath R; Traylor BR; Richman DP; Ng KL
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
[TBL] [Abstract][Full Text] [Related]
26. Fatal gastrointestinal hemorrhage after a single dose of dabigatran.
Kernan L; Ito S; Shirazi F; Boesen K
Clin Toxicol (Phila); 2012 Aug; 50(7):571-3. PubMed ID: 22800505
[TBL] [Abstract][Full Text] [Related]
27. Thrombolysis with alteplase for acute ischemic stroke patients with atrial fibrillation.
Zhang JB; Ding ZY; Yang Y; Sun W; Hai F; Sui XN; Li XY; Wang HZ; Wang XT; Zheng JL
Neurol Res; 2010 May; 32(4):353-8. PubMed ID: 20483000
[TBL] [Abstract][Full Text] [Related]
28. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
Ali A; Bailey C; Abdelhafiz AH
Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612
[TBL] [Abstract][Full Text] [Related]
29. A left MCA territory infarction during intravenous recombinant tissue plasminogen activator therapy for right MCA territory ischaemic stroke.
Lai CC; Hu CJ
Emerg Med J; 2006 Feb; 23(2):e11. PubMed ID: 16439725
[TBL] [Abstract][Full Text] [Related]
30. Successful intravenous thrombolysis in a 14-year-old boy with ischemic stroke.
Sampaio I; Abecasis F; Quintas S; Moreno T; Camilo C; Vieira M; Pinho e Melo T; Correia M
Pediatr Emerg Care; 2011 Jun; 27(6):541-3. PubMed ID: 21642792
[TBL] [Abstract][Full Text] [Related]
31. Right internal carotid artery occlusion during intravenous thrombolysis for left middle cerebral artery occlusion.
Yalcin-Cakmakli G; Akpinar E; Topcuoglu MA; Dalkara T
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):74-7. PubMed ID: 19110150
[TBL] [Abstract][Full Text] [Related]
32. Dabigatran etexilate: management in acute ischemic stroke.
Javedani PP; Horowitz BZ; Clark WM; Lutsep HL
Am J Crit Care; 2013 Mar; 22(2):169-76. PubMed ID: 23455868
[TBL] [Abstract][Full Text] [Related]
33. Stroke thrombolysis in patients taking dabigatran.
Jayathissa S; Gommans J; Harper P
Intern Med J; 2013 Jul; 43(7):826-8. PubMed ID: 23841763
[TBL] [Abstract][Full Text] [Related]
34. Acute ischemic stroke following cardioversion in a patient receiving dabigatran.
Faust AC; Smith MB; Kawalsky D
Ann Pharmacother; 2013 Oct; 47(10):1368-71. PubMed ID: 24259703
[TBL] [Abstract][Full Text] [Related]
35. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
Berrouschot J; Stoll A; Hogh T; Eschenfelder CC
Stroke; 2016 Jul; 47(7):1936-8. PubMed ID: 27301937
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
37. Recombinant tissue-type plasminogen activator (rt-PA) therapy in an acute stroke patient taking dabigatran etexilate: a case report and literature review.
Tabata E; Yasaka M; Wakugawa Y; Okada Y
Intern Med; 2014; 53(14):1515-7. PubMed ID: 25030563
[TBL] [Abstract][Full Text] [Related]
38. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Pfeilschifter W; Bohmann F; Baumgarten P; Mittelbronn M; Pfeilschifter J; Lindhoff-Last E; Steinmetz H; Foerch C
Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
[TBL] [Abstract][Full Text] [Related]
39. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
[TBL] [Abstract][Full Text] [Related]
40. Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report.
Tireli D; He J; Nordling MM; Wienecke T
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e123-e125. PubMed ID: 28479184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
